Rate of Complete Virologic Response at 12 Month and Associated Factors Among Chronic Hepatitis B Patients Treated With Tdf In Tash From 2019-2023

dc.contributor.advisorAbdulsemed Mohammed
dc.contributor.authorTigist Geres
dc.date.accessioned2026-06-22T15:52:58Z
dc.date.available2026-06-22T15:52:58Z
dc.date.issued2025-04-15
dc.description.abstractBackground: Chronic hepatitis B is a significant public health problem in sub-Saharan Africa, including Ethiopia. Despite the availability of antiviral therapies, achieving complete virological response could be challenged by several factors, including limited healthcare access, co-infections, and poor treatment adherence. Objective: To assess the rate of complete virological response and the associated factors among chronic hepatitis B patients followed at the Gastrointestinal follow-up clinic of Tikur Anbesa Specialized Hospital. Method: This retrospective cross-sectional study included patients receiving treatment for chronic hepatitis B at the Gastrointestinal follow-up clinic of Tikur Anbesa Specialized Hospital from 2019 to 2023. Data were collected through chart reviews by trained professionals, focusing on demographics, clinical characteristics, and risk factors like alcohol use, smoking, and treatment adherence. The data were entered into SPSS after verification for quality and completeness. Descriptive statistics summarized the data, while multivariable binary logistic regression identified predictors of complete virological response. Variables with a p-value < 0.05 in the regression analysis were considered statistically significant. years. Results: The study included 182 chronic hepatitis B patients, with 66.5% male and 50% aged 18–39 The overall complete virological response rate was 72.5% (95%CI,65.4%,78.9%).From 2019 to 2023, the response rates fluctuated between 62.1% and 90.2%. Among HBeAg-positive patients, the complete virological response rate was 67.6%. Multivariable analysis identified high baseline viral load (>20,000 IU/mL; AOR = 5.7, 95% CI: 1.13–18.13, p = 0.001), alcohol use (AOR = 4.43; 95% CI: 1.46–13.46, p = 0.01), smoking (AOR = 7.31; 95% CI: 1.74–30.77, p = 0.01), herbal medication use (AOR = 5.49; 95% CI: 1.51–19.99, p = 0.01), and non-adherence (AOR = 16.9; 95% CI: 10.55–122.16, p = 0.001) as independent predictors of delayed response. Conclusion and recommendation: While Ethiopia achieved notable complete virological response rates, delayed response persists due to high viral loads, substance use, and non adherence. Strengthening early diagnosis, adherence support, and culturally tailored behavioral interventions are critical to meeting WHO’s 2030 HBV elimination targets in resource-limited settings.
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/8439
dc.language.isoen_US
dc.publisherAddis Ababa University
dc.subjectRate of Complete Virologic Response at 12 Month
dc.titleRate of Complete Virologic Response at 12 Month and Associated Factors Among Chronic Hepatitis B Patients Treated With Tdf In Tash From 2019-2023
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Tigist_Geresu_2025_ETD.pdf
Size:
1.55 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: